Encephalitis Clinical Trial
Official title:
Description of neurolOgical Involvement Observed During SARS COV2 Infection
Description of the neurological impairment: clinico-radiological and electrophysilogical correlations
Describe short and long term clinical radiological and electrophysilogical presentations of neurological damage central and peripheral SARS COV2 infection Describe the association between neurological, respiratory and dysautonomic Determine the prognosis of neurological damages to short and long term. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02538094 -
tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis
|
N/A | |
Completed |
NCT00381433 -
Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid
|
Phase 1 | |
Completed |
NCT00031486 -
Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir
|
Phase 3 | |
Completed |
NCT00069303 -
Natural History of West Nile Virus Infection
|
N/A | |
Completed |
NCT02906631 -
Epidemiology and Prognosis of Encephalitis in Intensive Care
|
||
Completed |
NCT02367664 -
A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants
|
Phase 3 | |
Completed |
NCT00314132 -
Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.
|
Phase 3 | |
Terminated |
NCT00927953 -
Treatment of West Nile Virus With MGAWN1
|
Phase 2 | |
Recruiting |
NCT05393492 -
Regulating Emotions and Behaviors After Brain Injury
|
N/A | |
Terminated |
NCT04361344 -
Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection
|
N/A | |
Recruiting |
NCT04372615 -
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
|
Phase 2 | |
Completed |
NCT02714959 -
IL-2 in Refractory Autoimmune Encephalitis
|
Phase 1/Phase 2 | |
Completed |
NCT01092507 -
A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers
|
Phase 3 | |
Completed |
NCT01041573 -
Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population
|
Phase 3 | |
Not yet recruiting |
NCT04722328 -
Establishment of Prevention and Control System of Central Nervous System Infection
|
||
Recruiting |
NCT06067750 -
Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation
|
||
Not yet recruiting |
NCT06368648 -
CoMind Early Feasibility Study
|
||
Completed |
NCT02526550 -
Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX
|
Phase 4 | |
Completed |
NCT01694524 -
Nervous System Infections Among Patients With Febrile Seizure
|
N/A | |
Completed |
NCT04080921 -
Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis
|
Phase 1/Phase 2 |